{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:19:44Z","timestamp":1793121584867,"version":"4.5.0"},"reference-count":156,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>The extracellular matrix (ECM) is a complex noncellular network of (macro-)molecules that surrounds and supports diverse cells in tissues and organs. In cancer, ECM is a part of the tumor microenvironment (TME) that embeds its cellular components including cancer cells and the neighboring non-cancerous stromal cells such as fibroblasts, endothelial, and immune cells. Given the complexity of players and interactions that the ECM participates in and is exposed to in the TME, it does not come as a surprise that many of the processes that drive cancer progression take part precisely in the ECM compartment of the TME. Along with diverse glycoproteins and collagens, proteoglycans (PGs) are among the main components of the core ECM. PGs are composed of a protein core to which glycosaminoglycan chains are attached. Considering the structural diversity of these molecules and their \u2018hybrid\u2019 nature, it is not surprising that they are involved in a variety of processes that are vital for surrounding cells. Moreover, they are secreted by both cancer and stromal cells, contributing to the complexity of interactions in the TME. In prostate cancer, PGs have been shown to be involved in many steps of its progression; the most prominent examples include the seemingly tumor-promoting roles of versican, perlecan, and biglycan, and the tumor-suppressive roles of decorin and betaglycan. The role of syndecan 1 is a bit more complex; namely, the nature of its role is context dependent. In this narrative review article, the roles of PGs in prostate cancer progression and therapy resistance are discussed in more detail.<\/jats:p>","DOI":"10.3390\/medicina61122112","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:50:13Z","timestamp":1764244213000},"page":"2112","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proteoglycans in Prostate Cancer Progression and Therapy Resistance"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7082-9533","authenticated-orcid":false,"given":"Ivana","family":"Samar\u017eija","sequence":"first","affiliation":[{"name":"Laboratory for Epigenomics, Division of Molecular Medicine, Ru\u0111er Bo\u0161kovi\u0107 Institute, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The Evolving Tumor Microenvironment: From Cancer Initiation to Metastatic Outgrowth","volume":"41","author":"Joyce","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","article-title":"The Matrix in Cancer","volume":"21","author":"Cox","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1111\/febs.15776","article-title":"A Guide to the Composition and Functions of the Extracellular Matrix","volume":"288","author":"Karamanos","year":"2021","journal-title":"FEBS J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3892\/ijo.2022.5471","article-title":"Role of the Tumor Microenvironment in Cancer Hallmarks and Targeted Therapy (Review)","volume":"62","author":"Naser","year":"2023","journal-title":"Int. J. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.trecan.2025.05.003","article-title":"The Extracellular Matrix in Cancer: From Understanding to Targeting","volume":"11","author":"Chitty","year":"2025","journal-title":"Trends Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"eadg3840","DOI":"10.1126\/scitranslmed.adg3840","article-title":"The Extracellular Matrix as Hallmark of Cancer and Metastasis: From Biomechanics to Therapeutic Targets","volume":"16","author":"Sleeboom","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1111\/febs.14967","article-title":"Proteoglycans and Glycosaminoglycans as Regulators of Cancer Stem Cell Function and Therapeutic Resistance","volume":"286","author":"Vitale","year":"2019","journal-title":"FEBS J."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ahrens, T.D., Bang-Christensen, S.R., J\u00f8rgensen, A.M., L\u00f8ppke, C., Spliid, C.B., Sand, N.T., Clausen, T.M., Salanti, A., and Agerb\u00e6k, M.\u00d8. (2020). The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00749"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Barkovskaya, A., Buffone, A., \u017d\u00eddek, M., and Weaver, V.M. (2020). Proteoglycans as Mediators of Cancer Tissue Mechanics. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.569377"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Dituri, F., Gigante, G., Scialpi, R., Mancarella, S., Fabregat, I., and Giannelli, G. (2022). Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma. Cancers, 14.","DOI":"10.3390\/cancers14081902"},{"key":"ref_12","first-page":"10","article-title":"Cancer Statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrurol.2012.19","article-title":"Proteoglycans in Prostate Cancer","volume":"9","author":"Edwards","year":"2012","journal-title":"Nat. Rev. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Tzanakakis, G., Giatagana, E.-M., Kuskov, A., Berdiaki, A., Tsatsakis, A., Neagu, M., and Nikitovic, D. (2020). Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and Effectors. Cancers, 12.","DOI":"10.3390\/cancers12092401"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.matbio.2015.02.003","article-title":"Proteoglycan Form and Function: A Comprehensive Nomenclature of Proteoglycans","volume":"42","author":"Iozzo","year":"2015","journal-title":"Matrix Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1021\/acs.chemrev.8b00354","article-title":"Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics","volume":"118","author":"Karamanos","year":"2018","journal-title":"Chem. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","article-title":"Cancer Hallmarks Intersect with Neuroscience in the Tumor Microenvironment","volume":"41","author":"Hanahan","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wei, J., Hu, M., Huang, K., Lin, S., and Du, H. (2020). Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Pro-gression. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21175983"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"108095","DOI":"10.1016\/j.isci.2023.108095","article-title":"Global Impact of Proteoglycan Science on Human Diseases","volume":"26","author":"Xie","year":"2023","journal-title":"iScience"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Karagiorgou, Z., Fountas, P.N., Manou, D., Knutsen, E., and Theocharis, A.D. (2022). Proteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness. Cancers, 14.","DOI":"10.3390\/cancers14215328"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chen, J., Sun, T., You, Y., Wu, B., Wang, X., and Wu, J. (2021). Proteoglycans and Glycosaminoglycans in Stem Cell Homeostasis and Bone Tissue Regeneration. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.760532"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.05.003","article-title":"Proteoglycan Signaling in Tumor Angiogenesis and Endothelial Cell Autophagy","volume":"62","author":"Gubbiotti","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/03008207.2015.1045297","article-title":"The Role of Perlecan and Endorepellin in the Control of Tumor Angiogenesis and Endothelial Cell Autophagy","volume":"56","author":"Douglass","year":"2015","journal-title":"Connect. Tissue Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the Hallmarks of Metastasis","volume":"79","author":"Welch","year":"2019","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3892\/ol.2023.13749","article-title":"Prostate Cancer Bone Metastases Biology and Clinical Management (Review)","volume":"25","author":"Goode","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ban, J., Fock, V., Aryee, D.N.T., and Kovar, H. (2021). Mechanisms, Diagnosis and Treatment of Bone Metastases. Cells, 10.","DOI":"10.3390\/cells10112944"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.drudis.2010.05.009","article-title":"Proteoglycans on Bone Tumor Development","volume":"15","author":"Velasco","year":"2010","journal-title":"Drug Discov. Today"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/febs.13963","article-title":"Proteoglycan Neofunctions: Regulation of Inflammation and Autophagy in Cancer Biology","volume":"284","author":"Schaefer","year":"2017","journal-title":"FEBS J."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hynes, R.O., and Naba, A. (2012). Overview of the Matrisome\u2014An Inventory of Extracellular Matrix Constituents and Functions. Cold Spring Harb. Perspect. Biol., 4.","DOI":"10.1101\/cshperspect.a004903"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.matbio.2015.06.003","article-title":"The Extracellular Matrix: Tools and Insights for the \u201cOmics\u201d Era","volume":"49","author":"Naba","year":"2016","journal-title":"Matrix Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinform."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1369\/0022155420953922","article-title":"Versican: A Dynamic Regulator of the Extracellular Matrix","volume":"68","author":"Islam","year":"2020","journal-title":"J. Histochem. Cytochem."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zappia, J., Joiret, M., Sanchez, C., Lambert, C., Geris, L., Muller, M., and Henrotin, Y. (2020). From Translation to Protein Degradation as Mechanisms for Regulating Biological Functions: A Review on the SLRP Family in Skeletal Tissues. Biomolecules, 10.","DOI":"10.3390\/biom10010080"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lavorgna, T.R., Gressett, T.E., Chastain, W.H., and Bix, G.J. (2023). Perlecan: A Review of Its Role in Neurologic and Musculoskeletal Disease. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1189731"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hayes, A.J., Farrugia, B.L., Biose, I.J., Bix, G.J., and Melrose, J. (2022). Perlecan, a Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan with Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.856261"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Melrose, J. (2020). Perlecan, a Modular Instructive Proteoglycan with Diverse Functional Properties. Int. J. Biochem. Cell Biol., 128.","DOI":"10.1016\/j.biocel.2020.105849"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"107459","DOI":"10.1016\/j.vph.2024.107459","article-title":"Endostatin in Disease Modulation: From Cancer to Beyond","volume":"158","author":"Anakha","year":"2025","journal-title":"Vasc. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez-Vald\u00e9s, G., G\u00f3mez-Hevia, F., Lillo-Moya, J., Gonz\u00e1lez-Fern\u00e1ndez, T., Abelli, J., Cereceda-Cornejo, A., Bragato, M.C., Saso, L., and Rodrigo, R. (2023). Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030718"},{"key":"ref_41","first-page":"100312","article-title":"Syndecans in Cancer: A Review of Function, Expression, Prognostic Value, and Therapeutic Significance","volume":"27","author":"Czarnowski","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1369\/0022155420933709","article-title":"The Role of Glypicans in Cancer Progression and Therapy","volume":"68","author":"Li","year":"2020","journal-title":"J. Histochem. Cytochem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Song, H., Chou, J., Zhao, P., Chen, M., Yang, J., and Hao, X. (2025). Exploring TGFBR3 in Disease Pathogenesis: Mechanisms, Clinical Implications, and Pharmacological Modulation. J. Pharm. Anal., 101372.","DOI":"10.1016\/j.jpha.2025.101372"},{"key":"ref_44","first-page":"701","article-title":"Roles of Versican in Cancer Biology\u2014Tumorigenesis, Progression and Metastasis","volume":"28","author":"Du","year":"2013","journal-title":"Histol. Histopathol."},{"key":"ref_45","first-page":"963","article-title":"Elevated Levels of Versican but Not Decorin Predict Disease Progression in Early-Stage Prostate Cancer","volume":"4","author":"Ricciardelli","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"ref_46","first-page":"4786","article-title":"Modulation of Prostate Cancer Cell Attachment to Matrix by Versican","volume":"63","author":"Sakko","year":"2003","journal-title":"Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1074\/jbc.M606991200","article-title":"Formation of Hyaluronan- and Versican-Rich Pericellular Matrix by Prostate Cancer Cells Promotes Cell Motility","volume":"282","author":"Ricciardelli","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/or.2014.3252","article-title":"Cancer Stem Cell Differentiation: TGF\u03b21 and Versican May Trigger Molecules for the Organization of Tumor Spheroids","volume":"32","author":"Oktem","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"155440","DOI":"10.1016\/j.prp.2024.155440","article-title":"Splicing Variants of Versican in CD133+\/CD44+ Prostate Cancer Stem Cells","volume":"260","author":"Ayla","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1098\/rsif.2011.0825","article-title":"High-Resolution Microrheology in the Pericellular Matrix of Prostate Cancer Cells","volume":"9","author":"Nijenhuis","year":"2012","journal-title":"J. R. Soc. Interface"},{"key":"ref_51","first-page":"849","article-title":"Identification of a Unique Set of Genes Altered During Cell-Cell Contact in an in Vitro Model of Prostate Cancer Bone Metastasis","volume":"17","author":"Wang","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1158\/0008-5472.CAN-07-1330","article-title":"A Secreted Isoform of ErbB3 Promotes Osteonectin Expression in Bone and Enhances the Invasiveness of Prostate Cancer Cells","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.yexcr.2010.08.005","article-title":"Fibroblast and Prostate Tumor Cell Cross-Talk: Fibroblast Differentiation, TGF-\u03b2, and Extracellular Matrix Down-Regulation","volume":"316","author":"Gesteira","year":"2010","journal-title":"Exp. Cell Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e34611","DOI":"10.1097\/MD.0000000000034611","article-title":"Single-Cell and Bulk RNA Sequencing Reveal Cancer-Associated Fibroblast Heterogeneity and a Prognostic Signature in Prostate Cancer","volume":"102","author":"Liu","year":"2023","journal-title":"Medicine"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Treacy, P.-J., Martini, A., Falagario, U.G., Ratnani, P., Wajswol, E., Beksac, A.T., Wiklund, P., Nair, S., Kyprianou, N., and Durand, M. (2023). Association between Expression of Connective Tissue Genes and Prostate Cancer Growth and Progression. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087520"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/ijc.32792","article-title":"Integrative Clinical Transcriptome Analysis Reveals TMPRSS2-ERG Dependency of Prognostic Biomarkers in Prostate Adenocarcinoma","volume":"146","author":"Gerke","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Knezevic, D., Goddard, A.D., Natraj, N., Cherbavaz, D.B., Clark-Langone, K.M., Snable, J., Watson, D., Falzarano, S.M., Magi-Galluzzi, C., and Klein, E.A. (2013). Analytical Validation of the Oncotype DX Prostate Cancer Assay\u2014A Clinical RT-PCR Assay Optimized for Prostate Needle Biopsies. BMC Genom., 14.","DOI":"10.1186\/1471-2164-14-690"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/680136","article-title":"Proteoglycan Expression in Normal Human Prostate Tissue and Prostate Cancer","volume":"2013","author":"Suhovskih","year":"2013","journal-title":"ISRN Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.neo.2017.06.003","article-title":"Up-Regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer","volume":"19","author":"Jacobsen","year":"2017","journal-title":"Neoplasia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/iju.15080","article-title":"Stroma Biglycan Expression Can Be a Prognostic Factor in Prostate Cancers","volume":"30","author":"Furumido","year":"2023","journal-title":"Int. J. Urol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s43018-023-00594-z","article-title":"The Akt\/MTOR and MNK\/EIF4E Pathways Rewire the Prostate Cancer Translatome to Secrete HGF, SPP1 and BGN and Recruit Suppressive Myeloid Cells","volume":"4","author":"Brina","year":"2023","journal-title":"Nat. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2147\/IJGM.S515066","article-title":"Association of High Tumor-Stroma Ratio with Prostate Cancer Progression: Insights from Clinical and Genomic Data","volume":"18","author":"Xu","year":"2025","journal-title":"Int. J. Gen. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1593\/neo.09760","article-title":"Decorin Suppresses Prostate Tumor Growth through Inhibition of Epidermal Growth Factor and Androgen Receptor Pathways","volume":"11","author":"Hu","year":"2009","journal-title":"Neoplasia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.29252\/ibj.24.4.229","article-title":"While Urine and Plasma Decorin Remain Unchanged in Prostate Cancer, Prostatic Tissue Decorin Has a Prognostic Value","volume":"24","author":"Rezaie","year":"2020","journal-title":"Iran. Biomed. J."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Henke, A., Grace, O.C., Ashley, G.R., Stewart, G.D., Riddick, A.C.P., Yeun, H., O\u2019Donnell, M., Anderson, R.A., and Thomson, A.A. (2012). Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042516"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/gt.2014.110","article-title":"The Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin Inhibits Bone Metastasis in a Mouse Model of Human Prostate Cancer","volume":"22","author":"Xu","year":"2015","journal-title":"Gene Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10585-025-10365-y","article-title":"Morphological Heterogeneities in Prostate Cancer Bone Metastases Are Related to Molecular Subtypes and Prognosis","volume":"42","author":"Semenas","year":"2025","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41585-021-00476-y","article-title":"Exercise-Induced Myokines and Their Effect on Prostate Cancer","volume":"18","author":"Kim","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.yexcr.2013.01.023","article-title":"Lumican Expression, Localization and Antitumor Activity in Prostate Cancer","volume":"319","author":"Gesteira","year":"2013","journal-title":"Exp. Cell Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1158\/1078-0432.CCR-19-2389","article-title":"A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Na\u00efve Metastatic Prostate Cancer","volume":"26","author":"Corn","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Athanasiou, A., Tennstedt, P., Wittig, A., Huber, R., Straub, O., Schiess, R., and Steuber, T. (2021). A Novel Serum Biomarker Quintet Reveals Added Prognostic Value When Combined with Standard Clinical Parameters in Prostate Cancer Patients by Predicting Biochemical Recurrence and Adverse Pathology. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0259093"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12014-023-09439-4","article-title":"Development of a Predictive Model to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia by Integrating Serum Glycoproteomics and Clinical Variables","volume":"20","author":"Gabriele","year":"2023","journal-title":"Clin. Proteom."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3233\/CBM-150555","article-title":"The Small Leucine Rich Proteoglycan Fibromodulin Is Overexpressed in Human Prostate Epithelial Cancer Cell Lines in Culture and Human Prostate Cancer Tissue","volume":"16","author":"Reyes","year":"2016","journal-title":"Cancer Biomark."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5301\/jbm.5000184","article-title":"Gene Expression Profiling of Prostate Cancer\u2013Associated Genes Identifies Fibromodulin as Potential Novel Biomarker for Prostate Cancer","volume":"31","author":"Bettin","year":"2016","journal-title":"Int. J. Biol. Markers"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5215247","DOI":"10.1155\/2022\/5215247","article-title":"Fibromodulin Gene Variants (FMOD) as Potential Biomarkers for Prostate Cancer and Benign Prostatic Hyperplasia","volume":"2022","author":"Silva","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Xiao, Y., Lai, C., Hu, J., Mulati, Y., Xu, X., Luo, J., Kong, D., Liu, C., and Xu, K. (2024). Integrative Analysis Regarding the Correlation Between Collagen-Related Genes and Prostate Cancer. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12783-9"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Samar\u017eija, I. (2024). The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010079"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Samar\u017eija, I., and Konjevoda, P. (2023). Extracellular Matrix- and Integrin Adhesion Complexes-Related Genes in the Prognosis of Prostate Cancer Patients\u2019 Progression-Free Survival. Biomedicines, 11.","DOI":"10.3390\/biomedicines11072006"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.matbio.2014.04.005","article-title":"Matrilysin\/Matrix Metalloproteinase-7(MMP7) Cleavage of Perlecan\/HSPG2 Creates a Molecular Switch to Alter Prostate Cancer Cell Behavior","volume":"36","author":"Grindel","year":"2014","journal-title":"Matrix Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.18632\/oncotarget.7197","article-title":"Perlecan\/HSPG2 and Matrilysin\/MMP-7 as Indices of Tissue Invasion: Tissue Localization and Circulating Perlecan Fragments in a Cohort of 288 Radical Prostatectomy Patients","volume":"7","author":"Grindel","year":"2016","journal-title":"Oncotarget"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Grindel, B.J., Martinez, J.R., Tellman, T.V., Harrington, D.A., Zafar, H., Nakhleh, L., Chung, L.W., and Farach-Carson, M.C. (2018). Matrilysin\/MMP-7 Cleavage of Perlecan\/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-25435-3"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Tellman, T.V., Cruz, L.A., Grindel, B.J., and Farach-Carson, M.C. (2021). Cleavage of the Perlecan-Semaphorin 3a-Plexin A1-Neuropilin-1 (Pspn) Complex by Matrix Metalloproteinase 7\/Matrilysin Triggers Prostate Cancer Cell Dyscohesion and Migration. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063218"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-030-40146-7_6","article-title":"Flipping the Molecular Switch: Influence of Perlecan and Its Modifiers in the Tumor Microenvironment","volume":"1245","author":"Cruz","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/pros.23985","article-title":"Interaction between Prostate Cancer Cells and Prostate Fibroblasts Promotes Accumulation and Proteolytic Processing of Basement Membrane Proteins","volume":"80","author":"Ojalill","year":"2020","journal-title":"Prostate"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Samar\u017eija, I., Lukiyanchuk, V., Lon\u010dari\u0107, M., Rac-Justament, A., Stojanovi\u0107, N., Gorodetska, I., Kahya, U., Humphries, J.D., Fatima, M., and Humphries, M.J. (2024). The Extracellular Matrix Component Perlecan\/HSPG2 Regulates Radioresistance in Prostate Cancer Cells. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1452463"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Lima, T., Barros, A.S., Trindade, F., Ferreira, R., Leite-Moreira, A., Barros-Silva, D., Jer\u00f3nimo, C., Ara\u00fajo, L., Henrique, R., and Vitorino, R. (2022). Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study. Cancers, 14.","DOI":"10.3390\/cancers14082001"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1158\/0008-5472.CAN-18-0688","article-title":"Oncogenic Properties of NEAT1 in Prostate Cancer Cells Depend on the CDC5L\u2013AGRN Transcriptional Regulation Circuit","volume":"78","author":"Li","year":"2018","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Liu, Y., Wang, C.-L., Pang, Z.-Q., Gao, K., Shen, L.-K., Xu, W.-H., and Ren, M.-H. (2023). Endostatin 33 Peptide Is a Deintegrin \u03b16\u03b21 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer. J. Clin. Med., 12.","DOI":"10.3390\/jcm12051861"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1096\/fj.201601178R","article-title":"Endostatin Inhibits Androgen-Independent Prostate Cancer Growth by Suppressing Nuclear Receptor-Mediated Oxidative Stress","volume":"31","author":"Lee","year":"2017","journal-title":"FASEB J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1073\/pnas.1417660112","article-title":"Endostatin: A Novel Inhibitor of Androgen Receptor Function in Prostate Cancer","volume":"112","author":"Lee","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1582-4934.2008.00548.x","article-title":"E10A, an Adenovirus Carrying Human Endostatin Gene, in Combination with Docetaxel Treatment Inhibits Prostate Cancer Growth and Metastases","volume":"14","author":"Zhao","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/pros.20952","article-title":"Tumoristatic Effects of Endostatin in Prostate Cancer is Dependent on Androgen Receptor Status","volume":"69","author":"Isayeva","year":"2009","journal-title":"Prostate"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/pros.23503","article-title":"The Composition of Prostate Core Matrisome In Vivo and In Vitro Unveiled by Mass Spectrometric Analysis","volume":"78","author":"Ojalill","year":"2018","journal-title":"Prostate"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/path.4271","article-title":"Syndecan-1 (CD138) Contributes to Prostate Cancer Progression by Stabilizing Tumour-Initiating Cells","volume":"231","author":"Shimada","year":"2013","journal-title":"J. Pathol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/mc.22381","article-title":"Syndecan-1 up-Regulates microRNA-331-3p and Mediates Epithelial-to-Mesenchymal Transition in Prostate Cancer","volume":"55","author":"Fujii","year":"2016","journal-title":"Mol. Carcinog."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/pros.23391","article-title":"A Subset of High Gleason Grade Prostate Carcinomas Contain a Large Burden of Prostate Cancer Syndecan-1 Positive Stromal Cells","volume":"77","author":"Sharpe","year":"2017","journal-title":"Prostate"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/pros.23186","article-title":"Soluble Syndecan-1 (SDC1) Serum Level as an Independent Pre-Operative Predictor of Cancer-Specific Survival in Prostate Cancer","volume":"76","author":"Szarvas","year":"2016","journal-title":"Prostate"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41597-024-03696-0","article-title":"Reinterpretation of Prostate Cancer Pathology by Appl1, Sortilin and Syndecan-1 Biomarkers","volume":"11","author":"Logan","year":"2024","journal-title":"Sci. Data"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00428-023-03643-1","article-title":"Distinct Patterns of Biomarker Expression for Atypical Intraductal Proliferations in Prostate Cancer","volume":"485","author":"Martini","year":"2024","journal-title":"Virchows Arch."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Lazniewska, J., Li, K.L., Johnson, I.R.D., Sorvina, A., Logan, J.M., Martini, C., Moore, C., Ung, B.S.Y., Karageorgos, L., and Hickey, S.M. (2023). Dynamic Interplay between Sortilin and Syndecan-1 Contributes to Prostate Cancer Progression. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-40347-7"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.pathol.2023.05.004","article-title":"Appl1, Sortilin and Syndecan-1 Immunohistochemistry on Intraductal Carcinoma of the Prostate Provides Evidence of Retrograde Spread","volume":"55","author":"Sorvina","year":"2023","journal-title":"Pathology"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Logan, J.M., Hopkins, A.M., Martini, C., Sorvina, A., Tewari, P., Prabhakaran, S., Huzzell, C., Johnson, I.R.D., Hickey, S.M., and Ung, B.S.-Y. (2023). Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1. Cancers, 15.","DOI":"10.3390\/cancers15123215"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pathol.2022.08.001","article-title":"Aberrant Protein Expression of Appl1, Sortilin and Syndecan-1 during the Biological Progression of Prostate Cancer","volume":"55","author":"Martini","year":"2023","journal-title":"Pathology"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Heatlie, J.K., Lazniewska, J., Moore, C.R., Johnson, I.R.D., Nturubika, B.D., Williams, R., Ward, M.P., O\u2019Leary, J.J., Butler, L.M., and Brooks, D.A. (2025). Extracellular Vesicles and Tunnelling Nanotubes as Mediators of Prostate Cancer Intercellular Communication. Biomolecules, 15.","DOI":"10.3390\/biom15010023"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/2326-6066.CIR-23-0792","article-title":"Intracellular Osteopontin Promotes the Release of TNF\u03b1 by Mast Cells to Restrain Neuroendocrine Prostate Cancer","volume":"12","author":"Sulsenti","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"ref_106","first-page":"534","article-title":"The Expression of Syndecan-1 and -2 Is Associated with Gleason Score and Epithelial-Mesenchymal Transition Markers, E-Cadherin and \u03b2-Catenin, in Prostate Cancer","volume":"28","author":"Contreras","year":"2010","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/aja.2010.143","article-title":"Altered Expression Patterns of Syndecan-1 and -2 Predict Biochemical Recurrence in Prostate Cancer","volume":"13","author":"Ledezma","year":"2011","journal-title":"Asian J. Androl."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Santos, N.J., Barquilha, C.N., Barbosa, I.C., Macedo, R.T., Lima, F.O., Justulin, L.A., Barbosa, G.O., Carvalho, H.F., and Felisbino, S.L. (2021). Syndecan Family Gene and Protein Expression and Their Prognostic Values for Prostate Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168669"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"22359","DOI":"10.18632\/oncotarget.25009","article-title":"Development of a Reliable Assay to Measure Glypican-1 in Plasma and Serum Reveals Circulating Glypican-1 as a Novel Prostate Cancer Biomarker","volume":"9","author":"Levin","year":"2018","journal-title":"Oncotarget"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Campbell, D.H., Lund, M.E., Nocon, A.L., Cozzi, P.J., Frydenberg, M., De Souza, P., Schiller, B., Beebe-Dimmer, J.L., Ruterbusch, J.J., and Walsh, B.J. (2018). Detection of Glypican-1 (GPC-1) Expression in Urine Cell Sediments in Prostate Cancer. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196017"},{"key":"ref_111","first-page":"683.e11","article-title":"Development and Evaluation of the MiCheck Test for Aggressive Prostate Cancer","volume":"38","author":"Shore","year":"2020","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Quach, N.D., Kaur, S.P., Eggert, M.W., Ingram, L., Ghosh, D., Sheth, S., Nagy, T., Dawson, M.R., Arnold, R.D., and Cummings, B.S. (2019). Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-47874-2"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Kaur, S.P., Verma, A., Lee, H.K., Barnett, L.M., Somanath, P.R., and Cummings, B.S. (2021). Inhibition of Glypican-1 Expression Induces an Activated Fibroblast Phenotype in a Human Bone Marrow-Derived Stromal Cell-Line. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-88519-7"},{"key":"ref_114","first-page":"86","article-title":"Safety and Tolerability of Miltuximab\u00ae-a First in Human Study in Patients with Advanced Solid Cancers","volume":"9","author":"Sabanathan","year":"2021","journal-title":"Asia Ocean. J. Nucl. Med. Biol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Lund, M.E., Howard, C.B., Thurecht, K.J., Campbell, D.H., Mahler, S.M., and Walsh, B.J. (2020). A Bispecific T Cell Engager Targeting Glypican-1 Redirects T Cell Cytolytic Activity to Kill Prostate Cancer Cells. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07562-1"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13550-020-00637-x","article-title":"Targeted Beta Therapy of Prostate Cancer with 177Lu-Labelled Miltuximab\u00ae Antibody Against Glypican-1 (GPC-1)","volume":"10","author":"Yeh","year":"2020","journal-title":"EJNMMI Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.7150\/jca.14645","article-title":"Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization","volume":"7","author":"Truong","year":"2016","journal-title":"J. Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10142-024-01406-y","article-title":"GPC2 Promotes Prostate Cancer Progression via MDK-Mediated Activation of PI3K\/AKT Signaling Pathway","volume":"24","author":"Chen","year":"2024","journal-title":"Funct. Integr. Genom."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.eururo.2025.05.007","article-title":"Glypican-3 as a Radiotheranostic Target for Neuroendocrine Prostate Cancer","volume":"88","author":"Lee","year":"2025","journal-title":"Eur. Urol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/path.6063","article-title":"Oncofetal Protein Glypican-3 Is a Biomarker and Critical Regulator of Function for Neuroendocrine Cells in Prostate Cancer","volume":"260","author":"Butler","year":"2023","journal-title":"J. Pathol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1007\/s13277-015-4499-3","article-title":"Prognostic Significance of GPC5 Expression in Patients with Prostate Cancer","volume":"37","author":"Zhang","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3727\/096504017X15044461944385","article-title":"Overexpression of Glypican 5 (GPC5) Inhibits Prostate Cancer Cell Proliferation and Invasion via Suppressing Sp1-Mediated EMT and Activation of Wnt\/\u03b2-Catenin Signaling","volume":"26","author":"Sun","year":"2018","journal-title":"Oncol. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1158\/0008-5472.CAN-06-3117","article-title":"The Type III Transforming Growth Factor-\u03b2 Receptor as a Novel Tumor Suppressor Gene in Prostate Cancer","volume":"67","author":"Turley","year":"2007","journal-title":"Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/pros.20166","article-title":"Systemic Administration of a Soluble Betaglycan Suppresses Tumor Growth, Angiogenesis, and Matrix Metalloproteinase-9 Expression in a Human Xenograft Model of Prostate Cancer","volume":"63","author":"Bandyopadhyay","year":"2005","journal-title":"Prostate"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1158\/0008-5472.CAN-17-1051","article-title":"Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGF\u03b2RIII\u2013p38MAPK\u2013pS249\/T252RB Pathway","volume":"78","author":"Yu","year":"2018","journal-title":"Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1038\/s41388-019-0913-4","article-title":"Betaglycan Drives the Mesenchymal Stromal Cell Osteogenic Program and Prostate Cancer-Induced Osteogenesis","volume":"38","author":"Cook","year":"2019","journal-title":"Oncogene"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Korpetinou, A., Papachristou, D.J., Lampropoulou, A., Bouris, P., Labropoulou, V.T., Noulas, A., Karamanos, N.K., and Theocharis, A.D. (2015). Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines. BioMed Res. Int., 2015.","DOI":"10.1155\/2015\/690721"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"101227","DOI":"10.1016\/j.drup.2025.101227","article-title":"TGF\u03b2-Activated Asporin Interacts with STMN1 to Promote Prostate Cancer Docetaxel Chemoresistance and Metastasis by Upregulating the Wnt\/\u03b2-Catenin Signaling Pathway","volume":"81","author":"Ge","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1158\/0008-5472.CAN-18-2931","article-title":"Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression","volume":"79","author":"Hughes","year":"2019","journal-title":"Cancer Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/bjc.2017.15","article-title":"Asporin Is a Stromally Expressed Marker Associated with Prostate Cancer Progression","volume":"116","author":"Rochette","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e105450","DOI":"10.15252\/embj.2020105450","article-title":"Direct Interaction of \u03b2-Catenin with Nuclear ESM1 Supports Stemness of Metastatic Prostate Cancer","volume":"40","author":"Pan","year":"2021","journal-title":"EMBO J."},{"key":"ref_132","first-page":"530","article-title":"Expression of Endocan in Tissue Samples from Prostate Adenocarcinoma and Prostate Hyperplasia: A Comparative Retrospective Study","volume":"18","author":"Dadali","year":"2021","journal-title":"Urol. J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.7150\/ijms.21023","article-title":"Overexpression of Endothelial Cell-Specific Molecule 1 Correlates with Gleason Score and Expression of Androgen Receptor in Prostate Carcinoma","volume":"14","author":"Lai","year":"2017","journal-title":"Int. J. Med Sci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"35","DOI":"10.59566\/IJBS.2017.13035","article-title":"ESM-1 SiRNA Knockdown Decreased Migration and Expression of CXCL3 in Prostate Cancer Cells","volume":"13","author":"Rebollo","year":"2017","journal-title":"Int. J. Biomed. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"13886","DOI":"10.18632\/oncotarget.14684","article-title":"Loss of Endothelial Cell-Specific Molecule 1 Promotes the Tumorigenicity and Metastasis of Prostate Cancer Cells Through Regulation of the TIMP-1\/MMP-9 Expression","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5301\/tj.5000535","article-title":"Prognostic Value of Endocan in Prostate Cancer: Clinicopathologic Association between Serum Endocan Levels and Biochemical Recurrence after Radical Prostatectomy","volume":"103","author":"Arslan","year":"2017","journal-title":"Tumori J."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"de Moraes, G.F.A., Listik, E., Justo, G.Z., Vicente, C.M., and Toma, L. (2021). The Glypican Proteoglycans Show Intrinsic Interactions with Wnt-3a in Human Prostate Cancer Cells That Are Not Always Associated with Cascade Activation. BMC Mol. Cell Biol., 22.","DOI":"10.1186\/s12860-021-00361-x"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Kameda, T., Sugihara, T., Obinata, D., Oshima, M., Yamada, Y., Kimura, N., Takayama, K., Inoue, S., Takahashi, S., and Fujimura, T. (2024). Androgen Receptor and Osteoglycin Gene Expression Predicting Prognosis of Metastatic Prostate Cancer. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-74443-z"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-4598-5-9","article-title":"Perlecan, a Candidate Gene for the CAPB Locus, Regulates Prostate Cancer Cell Growth via the Sonic Hedgehog Pathway","volume":"5","author":"Datta","year":"2006","journal-title":"Mol. Cancer"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e37075","DOI":"10.1016\/j.heliyon.2024.e37075","article-title":"Extrachromosomal Circular DNA-Related SPOCK1 Contributes to Development and Enzalutamide Resistance of Prostate Cancer by Regulating Epithelial Mesenchymal Transition","volume":"10","author":"Yao","year":"2024","journal-title":"Heliyon"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Chen, M.-L., Ho, C.-J., Yeh, C.-M., Chen, S.-L., Sung, W.-W., Wang, S.-C., and Chen, C.-J. (2019). High SPOCK1 Expression Is Associated with Advanced Stage, T Value, and Gleason Grade in Prostate Cancer. Medicina, 55.","DOI":"10.3390\/medicina55070343"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s13046-019-1247-3","article-title":"Targeting the SPOCK1-Snail\/Slug Axis-Mediated Epithelial-to-Mesenchymal Transition by Apigenin Contributes to Repression of Prostate Cancer Metastasis","volume":"38","author":"Chien","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2147\/DDDT.S91321","article-title":"SPOCK1 Promotes Tumor Growth and Metastasis in Human Prostate Cancer","volume":"10","author":"Chen","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1007\/s13277-015-3628-3","article-title":"Plakophilin 1-Deficient Cells Upregulate SPOCK1: Implications for Prostate Cancer Progression","volume":"36","author":"Yang","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e7163","DOI":"10.7717\/peerj.7163","article-title":"Upregulation of SPOCK2 Inhibits the Invasion and Migration of Prostate Cancer Cells by Regulating the MT1-MMP\/MMP2 Pathway","volume":"7","author":"Liu","year":"2019","journal-title":"PeerJ"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Luo, J., Lai, C., Xu, X., Shi, J., Hu, J., Guo, K., Mulati, Y., Xiao, Y., Kong, D., and Liu, C. (2023). Mechanism of Prognostic Marker SPOCK3 Affecting Malignant Progression of Prostate Cancer and Construction of Prognostic Model. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11151-3"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Saraji, A., Duan, K., Watermann, C., Hempel, K., Roesch, M.C., Krupar, R., Stegmann-Frehse, J., Jonigk, D., Kuehnel, M.P., and Klapper, W. (2022). The Gene Expression Landscape of Prostate Cancer BM Reveals Close Interaction with the Bone Microenvironment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113029"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Samar\u017eija, I. (2021). Site-Specific and Common Prostate Cancer Metastasis Genes as Suggested by Meta-Analysis of Gene Expression Data. Life, 11.","DOI":"10.3390\/life11070636"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate Cancer: A Review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1758834017692779","article-title":"Docetaxel in Prostate Cancer: A Familiar Face as the New Standard in a Hormone-Sensitive Setting","volume":"9","author":"Puente","year":"2017","journal-title":"Ther. Adv. Med Oncol."},{"key":"ref_151","first-page":"312.e9","article-title":"Circulating Syndecan-1 Is Associated with Chemotherapy-Resistance in Castration-Resistant Prostate Cancer","volume":"36","author":"Szarvas","year":"2018","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"193","DOI":"10.18632\/oncoscience.136","article-title":"Versican Is a Potential Therapeutic Target in Docetaxel-Resistant Prostate Cancer","volume":"2","author":"Arichi","year":"2015","journal-title":"Oncoscience"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1158\/1541-7786.MCR-22-0099","article-title":"Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone\/Prednisone Treatment","volume":"20","author":"Sicotte","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajur.2015.04.011","article-title":"Mechanisms Navigating the TGF-\u03b2 Pathway in Prostate Cancer","volume":"2","author":"Cao","year":"2015","journal-title":"Asian J. Urol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"100613","DOI":"10.1016\/j.mcpro.2023.100613","article-title":"Identifying Patients with Rapid Progression from Hormone-Sensitive to Castration-Resistant Prostate Cancer: A Retrospective Study","volume":"22","author":"Pan","year":"2023","journal-title":"Mol. Cell. Proteom."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Walimbe, T., and Panitch, A. (2020). Proteoglycans in Biomedicine: Resurgence of an Underexploited Class of ECM Molecules. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01661"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/12\/2112\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:29:39Z","timestamp":1764246579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/12\/2112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":156,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["medicina61122112"],"URL":"https:\/\/doi.org\/10.3390\/medicina61122112","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]}}}